In 2023, Dr. Jeffrey M. Dayno earned $4.41M in total compensation at Harmony Biosciences Holdings, Inc., including $650.00K salary, $200.00K bonus and $3.55M in stock. Most recently sold 15,000 shares in Nov 2022. Currently holds stock worth $418.22K. 2+ years at the helm of Harmony Biosciences Holdings, Inc..
Compensation History
Annual executive compensation data for Dr. Jeffrey M. Dayno, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$4.41M
Salary
$650.00K
Bonus
$200.00K
Other
$13.92K
Salary
$650.00KBoard Justification
The compensation program is designed to attract, motivate, and reward executives while aligning their interests with those of stockholders.
Bonus
$200.00KBoard Justification
One-time cash retention bonus paid in January 2023, subject to repayment if employment is terminated for cause or voluntarily before December 15, 2024.
Other Compensation
$13.92KBoard Justification
401(k) matching contributions, life insurance premiums, long-term disability premiums.
Restricted Stock
Board Justification
Stock option granted in connection with his appointment as President and CEO, vesting 50% on May 25, 2025 and the remaining 50% in 24 equal monthly installments thereafter, subject to continued service.
Performance Metrics
Performance metrics include Net Product Revenue, clinical development programs, corporate transactions, financial health, and talent and culture.
Dr. Jeffrey M. Dayno
CEO of Harmony Biosciences Holdings, Inc.
Education
M.D. from Temple University School of Medicine
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1958 - 67 years ago
CEO of Harmony Biosciences Holdings, Inc. for
2 years 11 months (Jan 2023 - Present)
Previous Experience
Chief Medical Officer of Harmony Biosciences Holdings, Inc.
Other Harmony Biosciences Holdings, Inc. CEOs
Holdings
Track Dr. Jeffrey M. Dayno's stock holdings and portfolio value over time.
Total Stock Sold
$3.65M
$3.65M
80,000 HRMY shares
What if they kept their stock?
If Dr. Jeffrey M. Dayno didn't sell their stock, today they would have:
Extra HRMY80,000 shares worth $3.19M.
This is -12.74% and $465.34K less than what they got when they sold the stock.
Insider Trading
Dr. Jeffrey M. Dayno's recent stock transactions, purchases, and sales filed with the SEC.
$900.33K
HRMY at $60.02/share
Nov 3, 2022
Sale
$826.56K
HRMY at $55.10/share
Nov 1, 2022
Sale
$790.77K
HRMY at $43.45/share
Oct 19, 2021
Sale
$72.18K
HRMY at $40.10/share
Oct 6, 2021
Sale
$375.78K
HRMY at $37.58/share
Sep 7, 2021
Sale
$350.84K
HRMY at $35.08/share
Aug 26, 2021
Sale
$300.63K
HRMY at $30.21/share
Aug 10, 2021
Sale
$1.50K
HRMY at $30.00/share
Jul 22, 2021
Sale
Rivals
Compare Dr. Jeffrey M. Dayno with competitor CEOs and industry peers.